Xtant Medical to Issue Second Quarter 2022 Financial Results on August 4, 2022
Rhea-AI Summary
Xtant Medical Holdings, Inc. (NYSE American: XTNT) is set to announce its financial results for the second quarter ended June 30, 2022, on August 4, 2022, before market opening. The earnings conference call will occur at 9:00 AM ET, hosted by CEO Sean Browne and CFO Scott Neils. The company specializes in surgical solutions for spinal disorders, focusing on a broad range of orthobiologics and spinal implant systems. Following the call, a replay will be accessible on their website under ‘Investor Info’.
Positive
- Scheduled release of Q2 2022 financial results indicates proactive communication with investors.
- The upcoming conference call provides transparency regarding performance metrics.
Negative
- None.
News Market Reaction – XTNT
In the trading session that priced this news, XTNT declined 3.92%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BELGRADE, Mont., July 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the second quarter ended June 30, 2022, before the open of the financial markets on Thursday, August 4, 2022.
Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Thursday, August 4 at 9:00 AM ET to review results.
Conference Details
Conference Date: Thursday, August 4, 2022 - 9:00 AM ET
Conference Dial-in: 877-407-6184
International Dial-in: 201-389-0877
Conference Call Name: Xtant Medical Q2 2022 Financial Results
Webcast Registration: Click Here
Following the live call, a replay will be available on the Company’s website, www.xtantmedical.com, under “Investor Info.”
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.
Investor Relations Contact
David Carey
Lazar FINN Partners
Ph: 212-867-1762
Email: david.carey@finnpartners.com
